Skip to main content

Closed

IMNN: Imunon, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-346.8%

Financially safe

Stretched

Debt / equity0.27×

Interest coverage0.0×

Current ratio1.59×

Imunon, Inc.

IMNNNASDAQ Capital Market·USD·Closed

Imunon, Inc.

IMNNNASDAQ·USD·Closed

$1.59

−0.63%

$1.59

−$0.01 (0.63%)

52W Range

2thpctl

Volume

0.40×avg

Mkt Cap

4.01MUSD

P/E

-0.3TTM

Div Yield

–ann

52W Range

2thpctl

Volume

0.40×avg

Market Cap

4.01MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings